Prostate Cancer - Results from #28880

Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer - Abstract February 7, 2011

Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: Technique, early toxicity, and PSA response - Abstract February 7, 2011

Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: Can ADC values contribute to assess the aggressiveness of prostate cancer? - Abstract February 7, 2011

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer - Abstract February 7, 2011

Active surveillance for localized prostate cancer--current practices and recommendations - Abstract February 4, 2011

Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity - Abstract February 4, 2011

Initial treatment costs of organ-confined prostate cancer: A general perspective - Abstract February 4, 2011

Sipuleucel-T: In metastatic castration-resistant prostate cancer - Abstract February 4, 2011

Detection of ERG gene rearrangements and PTEN deletions in unsuspected prostate cancer of the transition zone - Abstract February 4, 2011

Prostate cancer: Comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map - Abstract February 4, 2011

Spirituality and end-of-life care in disadvantaged men dying of prostate cancer - Abstract February 4, 2011

Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partners - Abstract February 4, 2011

Dana-Farber researchers identify molecular predictor of metastatic prostate cancer February 3, 2011

Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer - Abstract February 3, 2011

Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer- Abstract February 3, 2011

Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans - Abstract February 3, 2011

Editor's Commentary - Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing February 2, 2011

Abiraterone acetate significantly improved overall survival for patients with metastatic advanced prostate cancer October 11, 2010

Study of investigational agent abiraterone acetate for metastatic advanced prostate cancer unblinded after meeting pre-determined criteria September 10, 2010

Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics - Abstract May 31, 2010

Page 1445 of 1447